Skip to main content

A Design Lab Pilot to Inform Strategies for Expanding Access to Medications for Opioid Use Disorder in Community Mental Health Centers

Healthcare
United States
Started September 19, 2026

A pilot Design Lab identified barriers and strategies to improving access to medications for opioid use disorder in community mental health settings. Expanding insurer reimbursement via a learning exchange was seen as most impactful and feasible

Need to find a specific claim? Search all statements.
🗳️ Join the conversation
10 statements to vote on • Your perspective shapes the analysis
📊 Progress to Consensus Analysis Need: 7+ participants, 20+ votes, 3+ votes per statement
Participants 0/7
Statements (10+ recommended) 10/10
Total Votes 0/20
💡 Progress updates live here. Final readiness is confirmed when all three requirements are met.

Your votes count

No account needed — your votes are saved and included in the consensus analysis. Create an account to track your voting history and add statements.

CLAIM Posted by admin • Sep 19, 2026
Stakeholders should collaborate to create a comprehensive strategy for expanding access to medications for opioid use disorder in community settings.
Vote options for this statement: agree, disagree, or unsure
Vote to see results
CLAIM Posted by admin • Sep 19, 2026
Community mental health centers will prescribe opioid use disorder medications with insufficient addiction medicine expertise if reimbursement is expanded without training requirements.
Vote options for this statement: agree, disagree, or unsure
Vote to see results
CLAIM Posted by admin • Sep 19, 2026
Community mental health centers should not become the primary focus for opioid use disorder treatments, as specialized clinics may provide better outcomes.
Vote options for this statement: agree, disagree, or unsure
Vote to see results
CLAIM Posted by admin • Sep 19, 2026
Community mental health centers should prioritize access to medications for opioid use disorder to reduce overdose deaths.
Vote options for this statement: agree, disagree, or unsure
Vote to see results
CLAIM Posted by admin • Sep 19, 2026
Patient education on the risks and benefits of medications for opioid use disorder should be prioritized in community mental health centers.
Vote options for this statement: agree, disagree, or unsure
Vote to see results
CLAIM Posted by admin • Sep 19, 2026
Whether or not reimbursement changes, all programs offering opioid use disorder medications must meet evidence-based clinical standards.
Vote options for this statement: agree, disagree, or unsure
Vote to see results
CLAIM Posted by admin • Sep 19, 2026
Expanding insurance reimbursement for opioid use disorder medications in community mental health centers will drain resources from other mental health services.
Vote options for this statement: agree, disagree, or unsure
Vote to see results
CLAIM Posted by admin • Sep 19, 2026
Insurers should increase reimbursement rates to community mental health centers that provide medications for opioid use disorder.
Vote options for this statement: agree, disagree, or unsure
Vote to see results
CLAIM Posted by admin • Sep 19, 2026
Insurer reimbursement policies must be reformed to improve access to medications for opioid use disorder in community mental health settings.
Vote options for this statement: agree, disagree, or unsure
Vote to see results
CLAIM Posted by admin • Sep 19, 2026
Pilot programs testing expanded access must measure both uptake and clinical outcomes before national implementation occurs.
Vote options for this statement: agree, disagree, or unsure
Vote to see results

💡 How This Works

  • • Add Statements: Post claims or questions (10-500 characters)
  • • Vote: Agree, Disagree, or Unsure on each statement
  • • Respond: Add detailed pro/con responses with evidence
  • • Consensus: After enough participation, analysis reveals opinion groups and areas of agreement

Society Speaks is open and independent. Your support keeps civic discussion free from advertising and commercial influence.

Support us